AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31827007 — intervention group
Group type: EXPERIMENTAL
Intervention: High birth weight
Number of subjects: 15045
Study 29614991 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete administration of chemotherapy cycles
Number of subjects: 392
Study 29614991 — intervention group
Group type: COMPARATOR
Intervention: Incomplete administration of chemotherapy cycles
Number of subjects: 392
Study 27259099 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (HIT), tri-weekly running-based program for 16 weeks
Number of subjects: 23
Study 27259099 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-exercise follow-up)
Number of subjects: 23
Study 25827032 — intervention group
Group type: EXPERIMENTAL
Intervention: In SHAPE program (12-month intervention including membership in a public fitness club and weekly meetings with a health promotion coach)
Number of subjects: 210
Study 25827032 — intervention group
Group type: COMPARATOR
Intervention: Fitness club membership alone (control group)
Number of subjects: 210
Study 23374164 — intervention group
Group type: EXPERIMENTAL
Intervention: F-fucoidan (FD)
Number of subjects: 0
Study 23374164 — intervention group
Group type: EXPERIMENTAL
Intervention: F-fucoidan (FD) + Fucoxanthin (FX)
Number of subjects: 0
Study 23374164 — intervention group
Group type: COMPARATOR
Intervention: Fucoxanthin (FX)
Number of subjects: 0
Study 19318600 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication Therapy Management (MTM) intervention
Number of subjects: 795
Study 19318600 — intervention group
Group type: COMPARATOR
Intervention: Mock MTM intervention (control group)
Number of subjects: 795
Study 19318600 — intervention group
Group type: COMPARATOR
Intervention: Both groups (opt-in and opt-out)
Number of subjects: 795
Study 18036090 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 572
Study 18036090 — intervention group
Group type: COMPARATOR
Intervention: Control group (community survey)
Number of subjects: 572
Study 15700733 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multivitamin supplement containing folic acid, beginning one month before conception and continuing through the first trimester.
Number of subjects: 0
Study 15700733 — intervention group
Group type: EXPERIMENTAL
Intervention: National preventive campaign on parents' behaviour, details not specified.
Number of subjects: 0
Study 11700852 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone Enanthate (TE) 100 mg weekly
Number of subjects: 51
Study 11700852 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone Enanthate (TE) 300 mg weekly
Number of subjects: 51
Study 11700852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 11700852 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone Enanthate (TE) 25 mg weekly
Number of subjects: 51
Study 11700852 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone Enanthate (TE) 50 mg weekly
Number of subjects: 51
Study 11700852 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone Enanthate (TE) 100 mg and 300 mg weekly
Number of subjects: 51
Study 11700852 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 51
Study 9221556 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 0
Study 9221556 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Number of subjects: 0
Study 9221556 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of TENS and tactile stimulation
Number of subjects: 0
Study 9221556 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham stimulation)
Number of subjects: 0
Study 9221556 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS without therapist
Number of subjects: 0
Study 7636643 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (3 mg of Zn acetate per day)
Number of subjects: 68
Study 7636643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 2539764 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil (2 puffs of 2 mg/puff)
Number of subjects: 12
Study 2539764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 911607 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning labels showing drugs known to interact
Number of subjects: 140
Study 911607 — intervention group
Group type: COMPARATOR
Intervention: No warning labels (control group)
Number of subjects: 140
Study 30341969 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided dosing of PPI
Number of subjects: 60
Study 30341969 — intervention group
Group type: COMPARATOR
Intervention: Conventional dosing of PPI
Number of subjects: 60
Study 26182832 — intervention group
Group type: EXPERIMENTAL
Intervention: CXCR2 antagonist AZD5069 (100 mg), twice daily orally for 6 days
Number of subjects: 30
Study 26182832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 26182832 — intervention group
Group type: EXPERIMENTAL
Intervention: CXCR2 antagonist AZD5069 (100 mg)
Number of subjects: 30
Study 26182832 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous G‐CSF on day 5
Number of subjects: 30
Study 25660414 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid supplementation twice daily
Number of subjects: 14
Study 25660414 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation twice daily
Number of subjects: 14
Study 24377096 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology Taping (KT), n = 20
Number of subjects: 65
Study 24377096 — intervention group
Group type: EXPERIMENTAL
Intervention: Quasi Kinesiology Taping (Quasi KT), n = 22
Number of subjects: 65
Study 24377096 — intervention group
Group type: COMPARATOR
Intervention: Multilayered Compression Therapy (MCT), n = 23
Number of subjects: 65
Study 20190243 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise training (cycling)
Number of subjects: 17
Study 20190243 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 17
Study 18684664 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 813
Study 18684664 — intervention group
Group type: COMPARATOR
Intervention: Optimal pharmacological treatment
Number of subjects: 813
Study 16634845 — intervention group
Group type: EXPERIMENTAL
Intervention: Intoxicated high HR responders
Number of subjects: 147
Study 16634845 — intervention group
Group type: EXPERIMENTAL
Intervention: Intoxicated low HR responders
Number of subjects: 147
Study 16634845 — intervention group
Group type: COMPARATOR
Intervention: Sober controls
Number of subjects: 147
Study 12816824 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (0.05% cream or 0.005% ointment) applied twice weekly
Number of subjects: 295
Study 12816824 — intervention group
Group type: COMPARATOR
Intervention: Emollient alone (placebo) applied twice weekly
Number of subjects: 295
Study 12816824 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate cream applied twice weekly
Number of subjects: 295
Study 12816824 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate ointment applied twice weekly
Number of subjects: 295
Study 11189684 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with flexible sigmoidoscopy (60‐cm sigmoidoscope)
Number of subjects: 74000
Study 11189684 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with chest X‐ray
Number of subjects: 74000
Study 11189684 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening men with digital rectal examination (DRE) plus serum prostate‐specific antigen (PSA)
Number of subjects: 74000
Study 11189684 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening women with CA125 and transvaginal ultrasound (TVU)
Number of subjects: 74000
Study 11189684 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care practices
Number of subjects: 74000
Study 9254261 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous perftoran infusion in 10-15 ml/kg dose
Number of subjects: 44
Study 9254261 — intervention group
Group type: COMPARATOR
Intervention: Control group (no perftoran infusion)
Number of subjects: 44
Study 7963413 — intervention group
Group type: EXPERIMENTAL
Intervention: Indeterminate recombinant immunoblot assay 3.0 patterns
Number of subjects: 89
Study 3297907 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracentesis (4-6 L/day until disappearance of ascites) and intravenous albumin infusion (40 g after each tap)
Number of subjects: 117
Study 3297907 — intervention group
Group type: COMPARATOR
Intervention: Diuretics (spironolactone 200-400 mg/day plus furosemide 40-240 mg/day)
Number of subjects: 117
Study 29120968 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR)
Number of subjects: 30
Study 29120968 — intervention group
Group type: COMPARATOR
Intervention: Calisthenics Training (CT)
Number of subjects: 30
Study 29231409 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint injection of salmon calcitonin (100 U, 4 mL total, 1 mL per acupoint)
Number of subjects: 90
Study 29231409 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of salmon calcitonin (100 U)
Number of subjects: 90
Study 29231409 — intervention group
Group type: COMPARATOR
Intervention: Blank group (0.9% sodium chloride injection, 1 mL per acupoint)
Number of subjects: 90
Study 24751286 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous endotracheal tube cuff pressure control system
Number of subjects: 284
Study 24751286 — intervention group
Group type: COMPARATOR
Intervention: Intermittent endotracheal tube cuff pressure control system
Number of subjects: 284
Study 24751286 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube with lumen for subglottic secretion drainage (SSD)
Number of subjects: 284
Study 24751286 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube without lumen for SSD
Number of subjects: 284
Study 21917326 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm Control (RhyC)
Number of subjects: 59
Study 21917326 — intervention group
Group type: COMPARATOR
Intervention: Rate Control (RaC)
Number of subjects: 59
Study 19837518 — intervention group
Group type: EXPERIMENTAL
Intervention: 50mg naltrexone
Number of subjects: 38
Study 19837518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 19837518 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone + smoking a single cigarette
Number of subjects: 38
Study 17535505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive appraisals (tolerance)
Number of subjects: 113
Study 17535505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive appraisals (interference)
Number of subjects: 113
Study 17535505 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity (symptom severity)
Number of subjects: 113
Study 17535505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive appraisals (tolerance and interference)
Number of subjects: 113
Study 16868803 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg once daily
Number of subjects: 37
Study 16868803 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 37
Study 16868803 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg or 20 mg
Number of subjects: 37
Study 12636954 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer counseling intervention
Number of subjects: 142
Study 12636954 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 142
Study 12636954 — intervention group
Group type: COMPARATOR
Intervention: Smoking 1-6 cigarettes/day
Number of subjects: 142
Study 12636954 — intervention group
Group type: COMPARATOR
Intervention: Smoking more than 6 cigarettes/day
Number of subjects: 142
Study 10868015 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic strength training (4 weeks duration)
Number of subjects: 38
Study 10868015 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular physiotherapy only)
Number of subjects: 38
Study 8865926 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1% amino acid dialysate (Nutrineal)
Number of subjects: 18
Study 7898097 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril (2.5-5.0 mg once daily)
Number of subjects: 0
Study 7898097 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 0
Study 3301458 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium (550 mg initially, 275 mg every 6 h thereafter)
Number of subjects: 100
Study 3301458 — intervention group
Group type: COMPARATOR
Intervention: Pirprofen (400 mg every 8 h until pain relief or 3-day trial end)
Number of subjects: 100
Study 30522497 — intervention group
Group type: EXPERIMENTAL
Intervention: Remotely supervised transcranial direct current stimulation (RS-tDCS) paired with cognitive training (CT) (2.0 mA × 20 min)
Number of subjects: 16
Study 30522497 — intervention group
Group type: EXPERIMENTAL
Intervention: Remotely supervised transcranial direct current stimulation (RS-tDCS) paired with cognitive training (CT)
Number of subjects: 16
Study 27296366 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based outpatient physiotherapy intervention (1-hour class weekly for 6 weeks)
Number of subjects: 256
Study 27296366 — intervention group
Group type: COMPARATOR
Intervention: Usual care (booklet about exercise and referral for physiotherapy if deemed appropriate)
Number of subjects: 256
Study 24695888 — intervention group
Group type: EXPERIMENTAL
Intervention: Food aromas in normal-weight subjects
Number of subjects: 48
Study 24695888 — intervention group
Group type: COMPARATOR
Intervention: Food aromas in obese subjects
Number of subjects: 48
Study 24695888 — intervention group
Group type: EXPERIMENTAL
Intervention: Responses to food aromas in obese subjects
Number of subjects: 48
Study 22738941 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week double-J stent placement
Number of subjects: 365
Study 22738941 — intervention group
Group type: COMPARATOR
Intervention: 6-week double-J stent placement
Number of subjects: 365
Study 19732856 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise (RVE) 11 times per week
Number of subjects: 20
Study 19732856 — intervention group
Group type: COMPARATOR
Intervention: Control group (bed rest only)
Number of subjects: 20
Study 19732856 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise (RVE)
Number of subjects: 20
Study 19732856 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 18703875 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based algorithm treatment
Number of subjects: 63
Study 18703875 — intervention group
Group type: COMPARATOR
Intervention: Individualised symptom-oriented treatment
Number of subjects: 63
Study 18703875 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study 18703875 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm treatment
Number of subjects: 63
Study 16462914 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib (50 mg, daily)
Number of subjects: 15
Study 16462914 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (50 mg, 3 times per day)
Number of subjects: 15
Study 16462914 — intervention group
Group type: COMPARATOR
Intervention: Placebo (orally for 3 days)
Number of subjects: 15
Study 12792208 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 16
Study 10872103 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic pentoxifylline sustained-release (SR) tablet
Number of subjects: 12
Study 10872103 — intervention group
Group type: COMPARATOR
Intervention: Trental 400
Number of subjects: 12
Study 8803512 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (Group G)
Number of subjects: 151
Study 8803512 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group P)
Number of subjects: 151
Study 1815531 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycyclin-Kapseln (test preparation)
Number of subjects: 20
Study 1815531 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation (R)
Number of subjects: 20
Study 6871470 — intervention group
Group type: EXPERIMENTAL
Intervention: random single-donor platelets (SD group)
Number of subjects: 54
Study 6871470 — intervention group
Group type: COMPARATOR
Intervention: random multiple-donor platelet concentrates (MD group)
Number of subjects: 54
Study 31045419 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS® Depression scale
Number of subjects: 158
Study 31045419 — intervention group
Group type: COMPARATOR
Intervention: Beck Depression Inventory (BDI‐II)
Number of subjects: 158
Study 30071449 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-savings program with financial literacy training
Number of subjects: 1400
Study 30071449 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1400
Study 26727241 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy enhancement arm with self-weighing using Carematix scale, instructed to weigh at least 3 days per week or every other day.
Number of subjects: 55
Study 26727241 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy enhancement arm with self-weighing
Number of subjects: 55
Study 25026096 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 25026096 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 60
Study 25026096 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 60
Study 25026096 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 22753128 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential self-focus writing
Number of subjects: 182
Study 22753128 — intervention group
Group type: COMPARATOR
Intervention: Control writing condition
Number of subjects: 182
Study 19240374 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose Th221 (60 mg/day)
Number of subjects: 45
Study 19240374 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose Th221 (20.4 mg/day)
Number of subjects: 45
Study 19240374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 17960962 — intervention group
Group type: EXPERIMENTAL
Intervention: Asenapine 5 mg b.i.d.
Number of subjects: 174
Study 17960962 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 3 mg b.i.d.
Number of subjects: 174
Study 17960962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 15909856 — intervention group
Group type: COMPARATOR
Intervention: Regimen I (standard high dose regimen) - 100 ml ASV loading dose followed by 50 ml every six hours
Number of subjects: 90
Study 15909856 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen II - 30 ml ASV loading dose followed by 30 ml continuous infusion every six hours
Number of subjects: 90
Study 15909856 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen III - 70 ml ASV loading dose followed by 30 ml continuous infusion every six hours
Number of subjects: 90
Study 12466688 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic tape
Number of subjects: 22
Study 12466688 — intervention group
Group type: COMPARATOR
Intervention: Placebo tape
Number of subjects: 22
Study 12466688 — intervention group
Group type: COMPARATOR
Intervention: No tape
Number of subjects: 22
Study 9585823 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-85-BV (3.5 mg of bacterial extracts)
Number of subjects: 56
Study 9585823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 8581845 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 20
Study 8581845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2632749 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg hydrocortisone (20 + 10 mg versus 10 + 20 mg, a.m./p.m.)
Number of subjects: 0
Study 319006 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 3 mg intravenous
Number of subjects: 10
Study 319006 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol (ordinary therapeutic dose by inhalation)
Number of subjects: 10
Study 29974808 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy
Number of subjects: 120
Study 29974808 — intervention group
Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitor
Number of subjects: 120
Study 29974808 — intervention group
Group type: COMPARATOR
Intervention: Psycho-education
Number of subjects: 120
Study 31877163 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Skills Education program
Number of subjects: 271
Study 31877163 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 271
Study 28408711 — intervention group
Group type: EXPERIMENTAL
Intervention: Commencing PD at 1 week (G1)
Number of subjects: 122
Study 28408711 — intervention group
Group type: EXPERIMENTAL
Intervention: Commencing PD at 2 weeks (G2)
Number of subjects: 122
Study 28408711 — intervention group
Group type: EXPERIMENTAL
Intervention: Commencing PD at 4 weeks (G3)
Number of subjects: 122
Study 26162609 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant CAPOX followed by chemoradiotherapy, surgery and adjuvant CAPOX plus cetuximab
Number of subjects: 155
Study 26162609 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant CAPOX followed by chemoradiotherapy, surgery and adjuvant CAPOX without cetuximab
Number of subjects: 155
Study 26162609 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant CAPOX followed by chemoradiotherapy, surgery and adjuvant CAPOX with cetuximab
Number of subjects: 155
Study 26162609 — intervention group
Group type: EXPERIMENTAL
Intervention: LCS-6 TT genotype
Number of subjects: 155
Study 26162609 — intervention group
Group type: EXPERIMENTAL
Intervention: LCS-6 TG genotype
Number of subjects: 155
Study 23791153 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (800 μg)
Number of subjects: 95
Study 23791153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 21334499 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 105
Study 21334499 — intervention group
Group type: COMPARATOR
Intervention: Relaxation Therapy
Number of subjects: 105
Study 21334499 — intervention group
Group type: COMPARATOR
Intervention: Usual Medical Care
Number of subjects: 105
Study 18071022 — intervention group
Group type: EXPERIMENTAL
Intervention: Leicester Cough Questionnaire (LCQ)
Number of subjects: 147